Among these mutations, only the mutation at Asn227 resulted in a lower molecular weight compared to the wild-type SBSPON protein in bladder cancer, suggesting that the potential of glycosylation modification at the Asn227 site (Fig. 5I). Here, SBSPON is linked to urinary bladder carcinoma.